Last updated: August 8, 2024
Sponsor: The University of Texas Health Science Center at San Antonio
Overall Status: Active - Recruiting
Phase
1
Condition
N/ATreatment
Bupivacaine Injection
Clinical Study ID
NCT05794828
HSC20220911H
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Posterior/lateral rib or vertebral fractures
Pancreatitis or pancreatic cancer
Renal colic
Back pain
Exclusion
Exclusion Criteria:
Unstable vitals
Infection or open wound over insertion site
Prior allergic reaction to local anesthetic
Pregnant females
Patients <18 years old
Altered mentation
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Bupivacaine Injection
Phase: 1
Study Start date:
September 15, 2023
Estimated Completion Date:
August 31, 2025
Study Description
Connect with a study center
Crozer Chester Medical Center
Ridley Park, Pennsylvania 19078
United StatesSite Not Available
Crozer Chester Medical Center
Upland, Pennsylvania 19013
United StatesActive - Recruiting
University Hospital
San Antonio, Texas 78229
United StatesActive - Recruiting
Baylor Scott & White
Temple, Texas 76508
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.